http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0112192-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_195b668eebb15e81ff32f7c5bdd74b05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cfc94318bca06890ac4c901f2efab838
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9735af553ea4ff9aae9a41ea77841463
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8adf1aa119f2fa8c92dc31e5ef07b387
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4741
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-428
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4741
filingDate 2000-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d337dd1bea9242b1cdd628a67d8f8ed4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c4a4c42f76ae971e2ff5bc5b1b71124
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3a5ab732b4d680e40664ff2e46d0008
publicationDate 2001-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0112192-A2
titleOfInvention Pharmaceutical compositions comprising a-(2-aminoethyl)-benzothiazolone and disodium cromoglycate or nedocromil
abstract The present invention provides a pharmaceutical composition, pharmaceutical product or kit comprising a first active ingredient (A) being 4-hydroxy-7-[2-[2-[3-[2-phenylethoxy]propylsulphonyl]ethylamino]ethyl]-1,3-benzothiazol-2(3H)-one or a pharmaceutically acceptable salt thereof, and a second active ingredient (B) being disodium cromoglycate or nedocromil, for use in the treatment of obstructive airways diseases.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7838535-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7842704-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8017602-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8058294-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7345060-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7709511-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8247564-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7951954-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7700782-B2
priorityDate 1999-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9324473-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231106311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127709052
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226598852
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129168314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11643
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID183812
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396575
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398877
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID183811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27503
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69373774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229780634
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129749464
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226432830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID50294
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68790646

Total number of triples: 48.